Search
for
Sort by
Research 541–570 of 1000+
- Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFNα-2b, and retinoic acid treatment over 2 years of follow-up
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Correlation between Androgenetic Alopecia and Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection in China
- Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseases
- Serum vitamin D, ferritin, and TSH in patients with telogen effluvium: a retrospective epidemiological study
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Acute Telogen Effluvium Related To COVID-19 Infection: A Review
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Regulatory T cells in dominant immunologic tolerance
- Rosmarinus officinalis and Skin: Antioxidant Activity and Possible Therapeutical Role in Cutaneous Diseases
- Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- Tribuloside acts on the PDE/cAMP/PKA pathway to enhance melanogenesis, melanocyte dendricity and melanosome transport
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit?
- Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients
- Evaluation of the effects of COVID‐19 pandemic on hair diseases through a web‐based questionnaire
- Alopecia and grey hair are associated with COVID‐19 Severity
- Italian Survey for the Evaluation of the Effects of Coronavirus Disease 2019 (COVID-19) Pandemic on Alopecia Areata Recurrence
- Dermatological Manifestations of COVID-19 Patients
- Investigating self-reported hair loss following covid-19 infection in the Iraqi population
- Possibilities for correcting diffuse alopecia associated with prior coronavirus infection (COVID-19)
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- COVID‐19 dermatological manifestations: results from the Mexican Academy of Dermatology COVID‐19 registry
- Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study
- Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?